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c14th International Congress on Infectious Diseases (ICID) Abs
presentation are unknown; it is possible that the immature
immune response of children < 2 years is dysregulated and
over-produces pro-inﬂammatory cytokines resulting in sys-
temic symptoms. Whereas in older children, the mature host
cellular immune response may be sufﬁcient to contain the
organism in granulomas withminimal systemic signs or symp-
toms. Further research is needed to understand the effect
of age and immune response to M. tuberculosis.
doi:10.1016/j.ijid.2010.02.1807
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A validated clinical practice guideline for community
health nurses working in tuberculosis Out-patient Clinics
A. Ahmed ∗, S. Soliman, L.A. Awad
Faculty of Nursing Mansoura University, Dakahlia, Egypt
Background: Tuberculosis is a major contributor to dis-
ease burden in developing countries; it is considered the
second fatal disease all over the world and the third most
important public health problem in Egypt. The direct causes
of increasing the burden of tuberculosis are the inconsistent
and fragmented health services. The nursing interventions of
tuberculosis in community settings require system of recom-
mendation that ensures the consistency of care. The present
study aimed at provid a valid clinical guideline that assist
nurses to intervene consistently to the newly diagnosed pul-
monary tuberculosis patient.
Methods: The needs analysis of community health nurses
working in out patient chest clinics in addition to the expec-
tation of newly diagnosed pulmonary tuberculosis patient
regarding nursing interventions. The guideline development
process established according to the criteria of experts of
guideline development organizations. The Scottish Intercol-
legiate Guidelines Network (Sign) research appraisal tools
were used for the critical appraisal phase of the obtained
evidence. AGREE instrument was used for assessing the
internal validity of the guideline. The guideline and apprised
for internal validity by academic nursing and medical staff,
nursing, and medical practitioners.
Results: The scores of all appraisers in relation to
scope and Purpose, stakeholder involvement, rigour of
development ranged from (62.9- 77.7%, 53.5- 77.7%, and
66.6-76.2%), respectively. While the scores for the clarity
and presentation were 50- 76.4, applicability were 61.9-
68.5, and editorial independence were 88- 93. The four
groups of revision strongly recommended the application of
the guideline.
Conclusion: In conclusion, the developed guideline based
on the needs of the intended users of nurses and end points
beneﬁciaries, i.e., patients. It was strongly recommended
by the reviewers and stockholders to be used in the out-
patients chest clinics. It is recommended that the guideline
should disseminate to the authoritative level to be applied in
the chest out patient clinics and evaluated for applicability
and achieved outcomes.
doi:10.1016/j.ijid.2010.02.1808
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enetic diversity of Mycobacterium tuberculosis popula-
ion in Bulgaria
. Valcheva
Institute of microbiology, Soﬁa, Bulgaria
Background: Molecular typing of Mycobacterium tuber-
ulosis isolates is a useful tool for epidemiological studies
t different levels. Tuberculosis remains an important pub-
ic health issue for Bulgaria, a Balkan country located in the
orld region with contrasting epidemiological situation for
uberculosis. Here we presents the insight into the popula-
ion structure and drug resistance of M. tuberculosis strains
urrently circulating in Bulgaria, as a necessary step towards
n implementation and better understanding of molecular
pidemiology of TB here. We further looked at our data
t a global scale through comparison with the international
ITVIT2 database.
Methods: Study sample included 133M. tuberculosis clin-
cal isolates originating from different regions of Bulgaria
nd analyzed by various DNA ﬁngerprinting methods We
dditionally investigated molecular basis of drug resistance
f the studied strains.
Results: Comparison with SITVIT2 database (Institut Pas-
eur de Guadeloupe) revealed a heterogeneous population
tructure of M. tuberculosis in Bulgaria. The Beijing geno-
ype strains were not found in spite of close links with
ussia in the recent and historical past. Novel 15/24-loci
IRU-VNTR format achieved the highest discrimination. We
dditionally investigated molecular basis of drug resistance
f the studied strains. Three types of the rpoB mutations
ere found in 20 of 27 RIF-resistant isolates; rpoB S531L
as the most frequent. Eleven (48%) of 23 INH-resistant
solates had katG S315T mutation. inhA -15C>T mutation
as detected in one INH-resistant isolate and three INH-
usceptible isolates. A mutation in embB306 was found in
of 11 EMB-resistant isolates.
Conclusion: This study gave a ﬁrst molecular snap-
hot of M. tuberculosis strains circulating in Bulgaria. It
emonstrated a heterogeneity of the Bulgarian M. tubercu-
osis population that appears to be dominated by several
orldwide distributed and Balkan speciﬁc spoligotypes.
omparison with genotyping data did not reveal a statisti-
al difference in the prevalence of drug resistance between
lustered and non-clustered isolates. Emergence and spread
f drug-resistant and MDR-TB in Bulgaria is not associated
ith any particular spoligotype or MIRU-VNTR cluster.
oi:10.1016/j.ijid.2010.02.1809
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ransmission of drug resistant tuberculosis and its impli-
ation for TB control in rural China
. Hu ∗, W. Jiang, W. Wang, B. Xu
School of Public Health, Fudan University, Shanghai, ChinaBackground: The transmission pattern of drug resistant
B might vary due to the difference in the geographic fea-
ure, socio-economic development and TB epidemic from
peciﬁc areas and populations. This might also matter how
